These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 20087482)
1. [Pregabalin--profile of efficacy and tolerability in neuropathic pain]. Stump P Drugs Today (Barc); 2009 Oct; 45 Suppl C():19-27. PubMed ID: 20087482 [TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related]
4. Pregabalin: new drug. Very similar to gabapentin. Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976 [TBL] [Abstract][Full Text] [Related]
5. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west. Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187 [TBL] [Abstract][Full Text] [Related]
6. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723 [TBL] [Abstract][Full Text] [Related]
7. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials. Roth T; van Seventer R; Murphy TK Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937 [TBL] [Abstract][Full Text] [Related]
10. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Tassone DM; Boyce E; Guyer J; Nuzum D Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610 [TBL] [Abstract][Full Text] [Related]
12. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. Sharma U; Griesing T; Emir B; Young JP Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study. Baron R; Brunnmüller U; Brasser M; May M; Binder A Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109 [TBL] [Abstract][Full Text] [Related]
15. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. Athanasakis K; Petrakis I; Karampli E; Vitsou E; Lyras L; Kyriopoulos J BMC Neurol; 2013 Jun; 13():56. PubMed ID: 23731598 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain. Sałat K; Librowski T; Nawiesniak B; Gluch-Lutwin M Neurol Res; 2013 Nov; 35(9):948-58. PubMed ID: 23816319 [TBL] [Abstract][Full Text] [Related]
17. Pregabalin for acute and chronic pain in adults. Moore RA; Straube S; Wiffen PJ; Derry S; McQuay HJ Cochrane Database Syst Rev; 2009 Jul; (3):CD007076. PubMed ID: 19588419 [TBL] [Abstract][Full Text] [Related]
18. Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study. Lampl C; Schweiger C; Haider B; Lechner A J Neurol; 2010 Aug; 257(8):1265-73. PubMed ID: 20221770 [TBL] [Abstract][Full Text] [Related]
19. Treatment of postherpetic neuralgia: focus on pregabalin. Cappuzzo KA Clin Interv Aging; 2009; 4():17-23. PubMed ID: 19503762 [TBL] [Abstract][Full Text] [Related]
20. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]